Genective Overview

  • Founded

  • 2011

Founded
  • Status

  • Private

  • Employees

  • 18

Employees
  • Latest Deal Type

  • Joint Venture

  • Financing Rounds

  • 1

Genective General Information

Description

Developer and provider of innovative biotech solutions in corn. The company creates, deregulates, and commercializes biotech corn traits, which deliver novel modes of action, especially in the control of field pests using experienced entomological team and well-equipped facilities.

Contact Information

Website
www.genective.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Agriculture
Primary Office
  • 5 Rue Saint-Germain
  • L'Auxerrois
  • 75001 Paris
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genective Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Genective‘s full profile, request access.

Request a free trial

Genective Patents

  • 18

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Genective Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220185850-A1 Pesticidal genes and methods of use Pending 13-Mar-2019 0000000000
CA-3133039-A1 Pesticidal genes and methods of use Pending 13-Mar-2019 0000000000
EP-3708669-A1 Pesticidal genes and methods of use Inactive 13-Mar-2019 0000000000 00
EP-3938520-A1 Pesticidal genes and methods of use Pending 13-Mar-2019 0000000000
AU-2016289877-A1 Method for gene optimization Active 06-Jul-2015 C12N15/8216
To view Genective’s complete patent history, request access »

Genective Executive Team (4)

Name Title Board Seat Contact Info
Qiaoni Jing Chief Executive Officer
Rick Emnett Vice President of Finance & Chief Financial Officer
Thomas Clark Chief Scientific Officer & Vice President of Research
You’re viewing 3 of 4 executive team members. Get the full list »

Genective Board Members (1)

Name Representing Role Since
0000í0 000000 00.0 Genective Chairman 000 0000
To view Genective’s complete board members history, request access »

Genective Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genective Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Genective‘s full profile, request access.

Request a free trial